David M. Geliebter

David M. Geliebter

Founder at Embark Healthcare

Health Technology
Finance
Commercial Services

Profile

David M.
Geliebter
is the founder of Critical Care Diagnostics, Inc. (2004) where he serves as Chairman.
He is also the founder of Remedy Pharmaceuticals, Inc. (2004) where he holds the title of Executive Chairman.
In 2019, Geliebter founded Learmont Pharmaceuticals, Inc. and serves as Executive Chairman.
Additionally, Geliebter is the founder of Embark Healthcare (2001) and holds the title of Managing Partner.
Mr. Geliebter is also the founder of Carson Group, Inc. (New York), Evolution Capital Management LLC, Martin Pharmaceuticals, Inc...
Currently, Geliebter is the Director at Woolsey Pharmaceuticals, Inc. Formerly, Geliebter served as Chairman at Access Scientific LLC and as Principal at WPP Group USA, Inc.

David M. Geliebter active positions

CompaniesPositionStart
Founder 01/04/2001
Founder 01/01/2004
Founder 20/11/2009
Director/Board Member -
Founder -
Founder 01/12/2019
All active positions of David M. Geliebter

Former positions of David M. Geliebter

CompaniesPositionEnd
Founder -
Corporate Officer/Principal -
Founder -
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░ -
See the detail of David M. Geliebter's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David M. Geliebter's experience

Connections

19

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Commercial Services

Finance

Finance

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. David M. Geliebter
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW